Imugene Limited (AU:IMU) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imugene Limited, a pioneer in cancer treatment innovation, has issued a disclaimer advising that the information presented is not personal investment advice and should not be the sole basis for investment decisions. The company stresses the need for professional investment advice and disclaims any liability for reliance on the information provided, which is subject to change and does not constitute an offer in the U.S. or other jurisdictions where it would be unlawful.
For further insights into AU:IMU stock, check out TipRanks’ Stock Analysis page.